These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel? Meurer LN; Slawson JG J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554 [No Abstract] [Full Text] [Related]
24. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. Henzl MR; Loomba PK J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327 [TBL] [Abstract][Full Text] [Related]
25. Menstrual manipulation: options for suppressing the cycle. Hicks CW; Rome ES Cleve Clin J Med; 2010 Jul; 77(7):445-53. PubMed ID: 20601618 [TBL] [Abstract][Full Text] [Related]
26. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Cromer BA; Bonny AE; Stager M; Lazebnik R; Rome E; Ziegler J; Camlin-Shingler K; Secic M Fertil Steril; 2008 Dec; 90(6):2060-7. PubMed ID: 18222431 [TBL] [Abstract][Full Text] [Related]
27. Merits of DMPA relative to other reversible contraceptive methods. Nelson A J Reprod Med; 2002 Sep; 47(9 Suppl):781-4. PubMed ID: 12380406 [TBL] [Abstract][Full Text] [Related]
28. The transdermal contraceptive patch: a new approach to hormonal contraception. Burkman RT Int J Fertil Womens Med; 2002; 47(2):69-76. PubMed ID: 11991433 [TBL] [Abstract][Full Text] [Related]
29. Comparing patient telephone callback rates for different hormonal birth control delivery systems. Victor I; Fink RA Am J Ther; 2006; 13(6):507-12. PubMed ID: 17122531 [TBL] [Abstract][Full Text] [Related]
35. Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review. Callahan R; Yacobson I; Halpern V; Nanda K Contraception; 2015 Dec; 92(6):514-22. PubMed ID: 26363431 [TBL] [Abstract][Full Text] [Related]
36. Contraceptive options for women in selected circumstances. Weisberg E Best Pract Res Clin Obstet Gynaecol; 2010 Oct; 24(5):593-604. PubMed ID: 20434405 [TBL] [Abstract][Full Text] [Related]
37. Progestin-only contraception: injectables and implants. Jacobstein R; Polis CB Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):795-806. PubMed ID: 24996766 [TBL] [Abstract][Full Text] [Related]
38. Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection. Morroni C; Grams M; Tiezzi L; Westhoff C Contraception; 2004 Jul; 70(1):19-23. PubMed ID: 15208048 [TBL] [Abstract][Full Text] [Related]
39. WHO statement on hormonal contraception and bone health. d'Arcangues C Contraception; 2006 May; 73(5):443-4. PubMed ID: 16627029 [No Abstract] [Full Text] [Related]
40. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK. Varney SJ; Guest JF Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]